Shanghai Runda Medical Technology Co., Ltd. Provides Earnings Guidance for the First Half Year of 2018
July 15, 2018
Share
Shanghai Runda Medical Technology Co., Ltd. Provided earnings guidance for the first half year of 2018. For the half year, the company according to preliminary statistics of its financial department, the company predicts that the total business revenue in the first half of 2018 will be about RMB 2,795 million, with a year-on-year increase of about 58%. It is predicted that the net profit belonging to shareholders of the listed company in the first half of 2018 will be between RMB 134.7 million and RMB 154 million, with a year-on-year increase of between 40% and 60%. The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will be between RMB 134.8 million and RMB 153.36 million, with a year-on-year increase of between 45% and 65%. The net cash flow in operational activities in the first half of 2018 will be about RMB 163.47 million, with an obvious improvement compared with that cash flow used in operating activities of RMB 92.27 million in the same period of the year before.
Shanghai Runda Medical Technology Co., Ltd. is a China-based company, principally engaged in the provision of in-vitro diagnostic devices and professional technique support services for all kinds of medical laboratories. The Company's integrated services include product portfolio options, professional and technical application services, informatization management of logistics warehousing distribution systems and all-round technical support. The Company also provides sales support and customer channel management, among others. The company mainly conducts its businesses within domestic market.